Innoviva (INVA) Free Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 10.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.69% |
| Sep 30, 2025 | -9.84% |
| Jun 30, 2025 | -17.69% |
| Mar 31, 2025 | -20.86% |
| Sep 30, 2024 | -21.34% |
| Jun 30, 2024 | -19.76% |
| Mar 31, 2024 | -23.91% |
| Sep 30, 2023 | 12.99% |
| Jun 30, 2023 | -21.78% |
| Mar 31, 2023 | -29.58% |
| Sep 30, 2022 | 49.76% |
| Jun 30, 2022 | 11.83% |
| Mar 31, 2022 | 8.57% |
| Sep 30, 2021 | 64.06% |
| Jun 30, 2021 | 17.83% |
| Mar 31, 2021 | 19.00% |
| Dec 31, 2020 | 21.23% |
| Sep 30, 2020 | 19.68% |
| Jun 30, 2020 | 52.18% |
| Mar 31, 2020 | 38.32% |
| Dec 31, 2019 | 47.00% |
| Sep 30, 2019 | 42.24% |
| Jun 30, 2019 | 65.55% |
| Mar 31, 2019 | 119.48% |
| Dec 31, 2018 | 107.49% |
| Sep 30, 2018 | 182.87% |
| Jun 30, 2018 | 187.62% |
| Mar 31, 2018 | 220.02% |
| Dec 31, 2017 | 129.52% |
| Sep 30, 2017 | 59.58% |
| Jun 30, 2017 | 34.34% |
| Mar 31, 2017 | 36.28% |
| Dec 31, 2016 | 35.96% |
| Sep 30, 2016 | 35.36% |
| Jun 30, 2016 | 39.53% |
| Mar 31, 2016 | 30.53% |
| Dec 31, 2015 | 31.66% |
| Sep 30, 2015 | 27.94% |
| Jun 30, 2015 | 27.28% |
| Mar 31, 2015 | 66.31% |
| Dec 31, 2014 | 43.47% |
| Sep 30, 2014 | -2.98% |
| Jun 30, 2014 | -40.72% |
| Mar 31, 2014 | -24.21% |
| Dec 31, 2013 | -37.91% |
| Sep 30, 2013 | -29.03% |